Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Chart & Stock Price History $10.47 0.00 (0.00%) As of 08/7/2025 09:37 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Oaktree Acquisition Corp. III Life Sciences Stock Price Performance The Oaktree Acquisition Corp. III Life Sciences (OACC) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 0.19%, reflecting recent market activity. As of the latest close, Oaktree Acquisition Corp. III Life Sciences traded at $10.47 with a market cap of $234.74 million and volume of 12,558 shares. Receive OACC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+0.19%3 Month Performance+0.19% OACC Stock Chart for Friday, August, 8, 2025 OACC Chart by TradingView Oaktree Acquisition Corp. III Life Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$10.47$10.47$10.47$10.4012,558 shs$234.74 million08/06/2025$10.47$10.47$10.47$10.3626,150 shs$234.74 million08/05/2025$10.45$10.47+0.19%$10.47$10.3626,150 shs$234.74 million08/04/2025$10.47$10.45-0.19%$10.47$10.457 shs$234.34 million08/01/2025$10.47$10.47$10.47$10.431,811 shs$234.79 million07/31/2025$10.47$10.47$10.47$10.475 shs$234.74 million07/30/2025$10.47$10.47$10.47$10.4544,446 shs$234.74 million07/29/2025$10.47$10.47$10.47$10.4544,446 shs$234.79 million07/28/2025$10.47$10.47$10.47$10.47162 shs$234.74 million07/25/2025$10.47$10.47$10.47$10.47143 shs$234.74 million Get the Latest News and Ratings for OACC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$10.45$10.47+0.19%$10.47$10.47143 shs$234.74 million07/23/2025$10.44$10.45+0.10%$10.47$10.44188,236 shs$234.29 million07/22/2025$10.44$10.44$10.44$10.442,004 shs$234.07 million07/21/2025$10.43$10.44+0.10%$10.44$10.442,004 shs$234.07 million07/18/2025$10.44$10.43-0.10%$10.44$10.4116,410 shs$233.84 million07/17/2025$10.42$10.44+0.19%$10.44$10.4029,901 shs$234.07 million07/16/2025$10.45$10.42-0.29%$10.44$10.4210,624 shs$233.67 million07/15/2025$10.44$10.45+0.10%$10.47$10.351,302 shs$234.29 million07/14/2025$10.41$10.44+0.29%$10.44$10.419,679 shs$234.07 million07/11/2025$10.40$10.41+0.10%$10.44$10.3941,860 shs$233.39 million07/10/2025$10.42$10.40-0.19%$10.45$10.354,871 shs$233.22 million07/09/2025$10.45$10.42-0.29%$10.47$10.42436 shs$233.62 million07/08/2025$10.41$10.45+0.38%$10.45$10.4220,496 shs$234.29 million07/07/2025$10.44$10.41-0.29%$10.41$10.41181 shs$233.39 million Related Companies Centerspace Stock Chart Orchid Island Capital Stock Chart Franklin BSP Realty Trust Stock Chart Patria Investments Stock Chart Noah Stock Chart NexPoint Residential Trust Stock Chart Associated Capital Group Stock Chart Getty Images Stock Chart Ares Acquisition Corporation II Stock Chart TPG RE Finance Trust Stock Chart Receive OACC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OACC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
